Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

被引:45
|
作者
Jones, Tiffanie [1 ]
Neboori, Hanmanth [2 ]
Wu, H. [2 ]
Yang, Qifeng [3 ]
Haffty, Bruce G. [2 ]
Evans, Susan [1 ]
Higgins, Susan [1 ]
Moran, Meena S. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] UMDNJ Robert Wood Johnson Sch Med, New Brunswick, NJ USA
[3] Shangdong Univ, Jinan, Peoples R China
关键词
TRIPLE-NEGATIVE PHENOTYPE; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPE; CONSERVATION THERAPY; AXILLARY DISSECTION; HORMONE-RECEPTOR; SURVIVAL; OUTCOMES; BIOPSY; WOMEN;
D O I
10.1245/s10434-013-2994-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer subtypes (BCS) determined from immunohistochemical staining have been correlated with molecular subtypes and associated with prognosis and outcomes, but there are limited data correlating these BCS and axillary node involvement. This study was conducted to assess whether BCS predicted for nodal metastasis or was associated with other clinicopathologic features at presentation. Patients with stage I/II disease who underwent breast-conserving surgery and axillary surgical assessment with available tissue blocks underwent a institutional pathological review and construction of a tissue microarray. The slides were stained for estrogen receptor, progesterone receptor, and HER-2/neu (HER-2) for classification into BCS. Nodal involvement and other clinicopathologic features were analyzed to assess associations between BCS and patient and tumor characteristics. Outcomes were calculated a function of BCS. The study cohort consisted of 453 patients (luminal A 48.6 %, luminal B 16.1 %, HER-2 11.0 %, triple negative 24.2 %), of which 22 % (n = 113) were node positive. There were no significant associations with BCS and pN stage, node positivity, or absolute number of nodes involved (p > 0.05 for all). However, there were significant associations with subtype and age at presentation (p < 0.001), method of detection (p = 0.049), tumor histology (p < 0.001), race (p = 0.041), and tumor size (pT stage, p < 0.001) by univariate and multivariate analysis. As expected, 10-year outcomes differed by BCS, with triple negative and HER-2 subtypes having the worse overall (p = 0.03), disease-free (p = 0.03), and distant metastasis-free survival (p < 0.01). There is a significant association between BCS and age, T stage, histology, method of detection, and race, but no associations to predict nodal involvement. If additionally validated, these findings suggest that BCS may not be a useful prognostic variable for influencing regional management considerations.
引用
收藏
页码:2866 / 2872
页数:7
相关论文
共 50 条
  • [1] Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?
    Tiffanie Jones
    Hanmanth Neboori
    H. Wu
    Qifeng Yang
    Bruce G. Haffty
    Susan Evans
    Susan Higgins
    Meena S. Moran
    Annals of Surgical Oncology, 2013, 20 : 2866 - 2872
  • [2] Regional Nodal Irradiation in Early-Stage Breast Cancer
    Whelan, Timothy J.
    Olivotto, Ivo A.
    Parulekar, Wendy R.
    Ackerman, Ida
    Chua, Boon H.
    Nabid, Abdenour
    Vallis, Katherine A.
    White, Julia R.
    Rousseau, Pierre
    Fortin, Andre
    Pierce, Lori J.
    Manchul, Lee
    Chafe, Susan
    Nolan, Maureen C.
    Craighead, Peter
    Bowen, Julie
    McCready, David R.
    Pritchard, Kathleen I.
    Gelmon, Karen
    Murray, Yvonne
    Chapman, Judy-Anne W.
    Chen, Bingshu E.
    Levine, Mark N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (04): : 307 - 316
  • [3] Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications
    Rao, Arunagiri Kuha Deva Magendhra
    Patel, Krishna
    Jyothiraj, Suneetha Korivi
    Meenakumari, Balaiah
    Sundersingh, Shirley
    Sridevi, Velusami
    Rajkumar, Thangarajan
    Pandey, Akhilesh
    Chatterjee, Aditi
    Gowda, Harsha
    Mani, Samson
    MOLECULAR ONCOLOGY, 2019, 13 (06) : 1342 - 1355
  • [4] Advances in regional nodal management of early-stage breast cancer
    Zhao Bi
    Yongsheng Wang
    ChineseJournalofCancerResearch, 2024, 36 (02) : 215 - 225
  • [5] Regional Nodal Irradiation in Early-Stage Breast Cancer REPLY
    Whelan, Timothy J.
    Olivotto, Ivo A.
    Levine, Mark N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19): : 1878 - 1879
  • [6] Advances in regional nodal management of early-stage breast cancer
    Bi, Zhao
    Wang, Yongsheng
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (02)
  • [7] Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer
    Caudle, Abigail S.
    Kuerer, Henry M.
    Le-Petross, Huong T.
    Yang, Wei
    Yi, Min
    Bedrosian, Isabelle
    Krishnamurthy, Savitri
    Fornage, Bruno D.
    Hunt, Kelly K.
    Mittendorf, Elizabeth A.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (11) : 3440 - 3447
  • [8] Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer
    Abigail S. Caudle
    Henry M. Kuerer
    Huong T. Le-Petross
    Wei Yang
    Min Yi
    Isabelle Bedrosian
    Savitri Krishnamurthy
    Bruno D. Fornage
    Kelly K. Hunt
    Elizabeth A. Mittendorf
    Annals of Surgical Oncology, 2014, 21 : 3440 - 3447
  • [9] Prognostic and predictive factors in early-stage breast cancer
    Cianfrocca, M
    Goldstein, LJ
    ONCOLOGIST, 2004, 9 (06): : 606 - 616
  • [10] Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer
    Li, Zheng
    Sergent, Fabrice
    Bolla, Michel
    Zhou, Yunfeng
    Gabelle-Flandin, Isabelle
    ONCOLOGY LETTERS, 2015, 9 (01) : 245 - 251